Lenalidomide-Associated ITP
Joint Authors
Arepally, Gowthami M.
Herold, Christina I.
Gasparetto, Cristina
Source
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-07-17
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Lenalidomide is a potent immunomodulatory agent being used increasingly for treatment of hematologic malignancies including multiple myeloma and myelodysplasia.
The common toxicities of lenalidomide, including dose-limiting myelosuppression, are well described.
However, the immunomodulatory properties of lenalidomide may give rise to unexpected autoimmune complications.
Herein, we describe a case of immune thrombocytopenic purpura (ITP) associated with use of lenalidomide.
American Psychological Association (APA)
Herold, Christina I.& Gasparetto, Cristina& Arepally, Gowthami M.. 2011. Lenalidomide-Associated ITP. Case Reports in Hematology،Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-487188
Modern Language Association (MLA)
Herold, Christina I.…[et al.]. Lenalidomide-Associated ITP. Case Reports in Hematology No. 2011 (2011), pp.1-4.
https://search.emarefa.net/detail/BIM-487188
American Medical Association (AMA)
Herold, Christina I.& Gasparetto, Cristina& Arepally, Gowthami M.. Lenalidomide-Associated ITP. Case Reports in Hematology. 2011. Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-487188
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-487188
